Guzip Biomarkers Corporation
PrivateLast Round
Seed
Mar 1, 2019
Company Overview
Guzip Biomarkers Corporation is a biotechnology company that develops DNA methylation-based diagnostic tools for the detection of endometrial cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Guzip Biomarkers Corporation Comparables
Compare Guzip Biomarkers Corporation with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| iStat Biomedical Co., Ltd. | 89% | |
| Epitype GmbH | 89% | |
| Self-screen B.V. | 86% | |
Guzip Biomarkers Corporation Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Mar 1, 2019 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 9, 2025
Monthly visitors increased 53% MoM, reaching 1.4K.
- Apr 18, 2025
Monthly visitors increased 153% MoM.
Guzip Biomarkers Corporation Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Guzip Biomarkers Corporation's valuation, stock price, and market status.